NEUMÜNSTER, Germany, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), and a global leader in medical cannabis ...

Tilray (TLRY) Medical announced the expansion of its medical cannabis extract portfolio in Germany. Tilray’s new medical cannabis offerings in Germany includes the introduction of an additional ...

There could be progress on the cannabis legalization front in the next five years. Whether Tilray benefits from this will depend on a lot of factors. The company's outlook remains risky and uncertain.

Tilray Brands, Inc. (TLRY) ended the recent trading session at $0.95, demonstrating a +1.05% swing from the preceding day's closing price. The stock outperformed the S&P 500, which registered a ...

NEUMÜNSTER, Germany, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), and a global leader in medical ...

One of the top cannabis stocks in the industry is Tilray Brands (TLRY-1.11%), and during that stretch, its valuation has crumbled, falling by a staggering 94%. The Canada-based company has been ...

Global Leader in Medical Cannabis Launches New Cannabis Extract Products and Formulations NEUMÜNSTER, Germany, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Tilray Medical ("Tilray"), a division of Tilray ...

Shares of Tilray Brands (NASDAQ: TLRY) were flying higher on Wednesday. The company's stock gained 7.5% as of 2:25 p.m. ET but gained as much as 20% earlier in the day. The leg up comes as the S&P ...

Tilray Inc has a 12-month low of $0.91 and a 12-month high of $2.97. The company has a current ratio of 2.54, a quick ratio of 1.58 and a debt-to-equity ratio of 0.10.

NEW YORK and LEAMINGTON, Ontario, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or “Company”) (Nasdaq: TLRY; TSX: TLRY), a global ...